Correlation Between Akero Therapeutics and Navidea Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Navidea Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Navidea Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Navidea Biopharmaceuticals, you can compare the effects of market volatilities on Akero Therapeutics and Navidea Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Navidea Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Navidea Biopharmaceutica.
Diversification Opportunities for Akero Therapeutics and Navidea Biopharmaceutica
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Akero and Navidea is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Navidea Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Navidea Biopharmaceutica and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Navidea Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Navidea Biopharmaceutica has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Navidea Biopharmaceutica go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Navidea Biopharmaceutica
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 1.07 times more return on investment than Navidea Biopharmaceutica. However, Akero Therapeutics is 1.07 times more volatile than Navidea Biopharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Navidea Biopharmaceuticals is currently generating about -0.5 per unit of risk. If you would invest 4,420 in Akero Therapeutics on September 12, 2024 and sell it today you would lose (1,356) from holding Akero Therapeutics or give up 30.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 1.14% |
| Values | Daily Returns |
Akero Therapeutics vs. Navidea Biopharmaceuticals
Performance |
| Timeline |
| Akero Therapeutics |
| Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Akero Therapeutics and Navidea Biopharmaceutica Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Navidea Biopharmaceutica
The main advantage of trading using opposite Akero Therapeutics and Navidea Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Navidea Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Navidea Biopharmaceutica will offset losses from the drop in Navidea Biopharmaceutica's long position.| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
| Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |